The UCAN Company
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
The UCAN Company - overview
Established
2006
Location
-, CT, US
Primary Industry
Biotechnology
About
Founded in 2006 and based in Connecticut, US, The UCAN Company is a biotechnology company that focuses on the development of therapeutic products for the treatment of cure metabolic disorders.
Current Investors
S2G Ventures, Eighteen94 Capital, Connecticut Innovations
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.ucan.co
Company Stage
Series D
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.